Systematic review and meta-analysis of randomised controlled trials testing the effects of vitamin C supplementation on blood lipids

Clinical Nutrition

Volumn 35, Issue 3, 2016, Pages 626-637

  Ashor, Ammar W ^a,b   Siervo, Mario ^a,c   van der Velde, Femke ^a   Willis, Naomi D ^a   Mathers, John C ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b MUSTANSIRIYAH UNIVERSITY   (Iraq)

^c MRC HUMAN NUTRITION RESEARCH   (United Kingdom)

Author keywords

Ascorbic acid; Cardiovascular risk; Cholesterol; Lipoproteins; Nutritional supplements; Triglycerides

Indexed keywords

ASCORBIC ACID; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; ANTILIPEMIC AGENT; ANTIOXIDANT; CARDIOVASCULAR AGENT;

AGE DISTRIBUTION; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; DRUG MECHANISM; DYSLIPIDEMIA; HUMAN; LIPID BLOOD LEVEL; META ANALYSIS; OUTCOME ASSESSMENT; PERSONALIZED MEDICINE; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SECONDARY PREVENTION; SYSTEMATIC REVIEW; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; ASCORBIC ACID DEFICIENCY; DIET THERAPY; HYPERLIPIDEMIA; OXIDATIVE STRESS; PATHOPHYSIOLOGY; REPRODUCIBILITY; RISK;

ANTIOXIDANTS; ASCORBIC ACID; ASCORBIC ACID DEFICIENCY; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; DYSLIPIDEMIAS; HUMANS; HYPERLIPIDEMIAS; HYPOLIPIDEMIC AGENTS; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS; RISK;

EID: 84936802449     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2015.05.021     Document Type: Article

References (66)

1. Dahlof B. Cardiovascular disease risk factors: epidemiology and risk assessment. Am J Cardiol 2010, 105:3A-9A.
2. Abdel-Maksoud M., Sazonov V., Gutkin S.W., Hokanson J.E. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes. J Cardiovasc Pharmacol 2008, 51:331-351.
3. Preiss D., Sattar N. Lipids, lipid modifying agents and cardiovascular risk: a review of the evidence. Clin Endocrinol (Oxf) 2009, 70:815-828.
4. Wang Y., Chun O.K., Song W.O. Plasma and dietary antioxidant status as cardiovascular disease risk factors: a review of human studies. Nutrients 2013, 5:2969-3004.
5. Khaw K.T., Bingham S., Welch A., Luben R., Wareham N., Oakes S., et al. Relation between plasma ascorbic acid and mortality in men and women in epic-norfolk prospective study: a prospective population study. European prospective investigation into cancer and nutrition. Lancet 2001, 357:657-663.
6. Mandl J., Szarka A., Banhegyi G. Vitamin C: update on physiology and pharmacology. Br J Pharmacol 2009, 157:1097-1110.
7. May J.M., Harrison F.E. Role of vitamin C in the function of the vascular endothelium. Antioxid Redox Signal 2013, 19:2068-2083.
8. McRae M.P. Vitamin C supplementation lowers serum low-density lipoprotein cholesterol and triglycerides: a meta-analysis of 13 randomized controlled trials. J Chiropr Med 2008, 7:48-58.
9. Charlton-Menys V., Durrington P.N. Human cholesterol metabolism and therapeutic molecules. Exp Physiol 2008, 93:27-42.
10. Chambial S., Dwivedi S., Shukla K.K., John P.J., Sharma P. Vitamin C in disease prevention and cure: an overview. Indian J Clin Biochem 2013, 28:314-328.
11. Dobson H.M., Muir M.M., Hume R. The effect of ascorbic acid on the seasonal variations in serum cholesterol levels. Scott Med J 1984, 29:176-182.
12. Bostom A.G., Hume A.L., Eaton C.B., Laurino J.P., Yanek L.R., Regan M.S., et al. The effect of high-dose ascorbate supplementation on plasma lipoprotein(a) levels in patients with premature coronary heart disease. Pharmacotherapy 1995, 15:458-464.
13. Paolisso G., Balbi V., Volpe C., Varricchio G., Gambardella A., Saccomanno F., et al. Metabolic benefits deriving from chronic vitamin C supplementation in aged non-insulin dependent diabetics. J Am Coll Nutr 1995, 14:387-392.
14. Woodside J.V., McCall D., McGartland C., Young I.S. Micronutrients: dietary intake v. Supplement use. Proc Nutr Soc 2005, 64:543-553.
15. Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011].
16. Liberati A., Altman D.G., Tetzlaff J., Mulrow C., Gotzsche P.C., Ioannidis J.P., et al. The prisma statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009, 339:b2700.
17. Jadad A.R., Moore R.A., Carroll D., Jenkinson C., Reynolds D.J., Gavaghan D.J., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 1996, 17:1-12.
18. Menne I.V., Grey P.C., Kotze J.P., Sommers D.K., Brown J.M., Spies J.H. Ascorbic acid and blood lipid and uric acid levels of students. S Afr Med J 1975, 49:2225-2228.
19. Mostafa Se-D., Garner D.D., Garrett L., Whaley R.F., el-Sekate M., Kiker M. Beneficial effects of vitamin C on risk factors of cardiovascular diseases. J Egypt Public Health Assoc 1989, 64:123-133.
20. Elbourne D.R., Altman D.G., Higgins J.P., Curtin F., Worthington H.V., Vail A. Meta-analyses involving cross-over trials: methodological issues. Int J Epidemiol 2002, 31:140-149.
21. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. Br Med J 1997, 315:629-634.
22. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
23. Aro A., Kyllastinen M., Kostiainen E., Gref C.G., Elfving S., Uusitalo U. No effect on serum lipids by moderate and high doses of vitamin C in elderly subjects with low plasma ascorbic acid levels. Ann Nutr Metab 1988, 32:133-137.
24. Nyyssonen K., Poulsen H.E., Hayn M., Agerbo P., Porkkala-Sarataho E., Kaikkonen J., et al. Effect of supplementation of smoking men with plain or slow release ascorbic acid on lipoprotein oxidation. Eur J Clin Nutr 1997, 51:154-163.
25. Askari G., Hajishafiee M., Ghiasvand R., Hariri M., Darvishi L., Ghassemi S., et al. Quercetin and vitamin C supplementation: effects on lipid profile and muscle damage in male athletes. Int J Prev Med 2013, 4:S58-S62.
26. Bo S., Ciccone G., Durazzo M., Gambino R., Massarenti P., Baldi I., et al. Efficacy of antioxidant treatment in reducing resistin serum levels: a randomized study. PLoS Clin Trials 2007, 2:e17.
27. Cerna O., Ramacsay L., Ginter E. Plasma lipids, lipoproteins and atherogenic index in men and women administered vitamin C. Cor Vasa 1992, 34:246-254.
28. Fotherby M.D., Williams J.C., Forster L.A., Craner P., Ferns G.A. Effect of vitamin C on ambulatory blood pressure and plasma lipids in older persons. J Hypertens 2000, 18:411-415.
29. Gatto L.M., Hallen G.K., Brown A.J., Samman S. Ascorbic acid induces a favorable lipoprotein profile in women. J Am Coll Nutr 1996, 15:154-158.
30. Jacques P.F., Sulsky S.I., Perrone G.E., Jenner J., Schaefer E.J. Effect of vitamin C supplementation on lipoprotein cholesterol, apolipoprotein, and triglyceride concentrations. Ann Epidemiol 1995, 5:52-59.
31. Kim M.K., Sasaki S., Sasazuki S., Okubo S., Hayashi M., Tsugane S. Long-term vitamin C supplementation has no markedly favourable effect on serum lipids in middle-aged japanese subjects. Br J Nutr 2004, 91:81-90.
32. Tofler G.H., Stec J.J., Stubbe I., Beadle J., Feng D., Lipinska I., et al. The effect of vitamin C supplementation on coagulability and lipid levels in healthy male subjects. Thromb Res 2000, 100:35-41.
33. Yanai H., Morimoto M. Effect of ascorbate on serum lipids and urate metabolism during exhaustive training. Clin Sci (Lond) 2004, 106:107-109.
34. Bhatt J.K., Thomas S., Nanjan M.J. Effect of oral supplementation of vitamin C on glycemic control and lipid profile in patients with type 2 diabetes mellitus. Int J Pharm Pharm Sci 2012, 4:524-527.
35. Chaudhari H.V., Dakhale G.N., Chaudhari S., Kolhe S., Hiware S., Mahatme M. The beneficial effect of vitamin C supplementation on serum lipids in type 2 diabetic patients: a randomized double blind study. Int J Diabetes Metabol 2012, 20:53-58.
36. Mazloom Z., Hejazi N., Dabbaghmanesh M.H., Tabatabaei H.R., Ahmadi A., Ansar H. Effect of vitamin C supplementation on postprandial oxidative stress and lipid profile in type 2 diabetic patients. Pak J Biol Sci PJBS 2011, 14:900-904.
37. Tousoulis D., Antoniades C., Vasiliadou C., Kourtellaris P., Koniari K., Marinou K., et al. Effects of atorvastatin and vitamin C on forearm hyperaemic blood flow, asymmentrical dimethylarginine levels and the inflammatory process in patients with type 2 diabetes mellitus. Heart (British Cardiac Society) 2007, 93:244-246.
38. Bishop N., Schorah C.J., Wales J.K. The effect of vitamin C supplementation on diabetic hyperlipidaemia: a double blind, crossover study. Diabet Med 1985, 2:121-124.
39. Ginter E., Zdichynec B., Holzerova O., Ticha E., Kobza R., Koziakova M., et al. Hypocholesterolemic effect of ascorbic acid in maturity-onset diabetes mellitus. Int J Vitam Nutr Res 1978, 48:368-373.
40. Gutierrez A.D., Duran-Valdez E., Robinson I., de Serna D.G., Schade D.S. Does short-term vitamin C reduce cardiovascular risk in type 2 diabetes?. Endocr Pract 2013, 19:785-791.
41. Lu Q., Bjorkhem I., Wretlind B., Diczfalusy U., Henriksson P., Freyschuss A. Effect of ascorbic acid on microcirculation in patients with type ii diabetes: a randomized placebo-controlled cross-over study. Clin Sci (Lond) 2005, 108:507-513.
42. Mahmoudabadi M.M., Djalali M., Djazayery S.A., Keshavarz S.A., Eshraghian M.R., Yaraghi A.A., et al. Effects of eicosapentaenoic acid and vitamin C on glycemic indices, blood pressure, and serum lipids in type 2 diabetic iranian males. J Res Med Sci 2011, 16(Suppl. 1):S361-S367.
43. Bordia A.K. The effect of vitamin C on blood lipids, fibrinolytic activity and platelet adhesiveness in patients with coronary artery disease. Atherosclerosis 1980, 35:181-187.
44. Gokce N., Keaney J.F., Frei B., Holbrook M., Olesiak M., Zachariah B.J., et al. Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 1999, 99:3234-3240.
45. Singhal S., Gupta R., Goyle A. Comparison of antioxidant efficacy of vitamin E, vitamin C, vitamin A and fruits in coronary heart disease: a controlled trial. J Assoc Physicians India 2001, 49:327-331.
46. Fuller C.J., May M.A., Martin K.J. The effect of vitamin E and vitamin C supplementation on ldl oxidizability and neutrophil respiratory burst in young smokers. J Am Coll Nutr 2000, 19:361-369.
47. Mulholland C.W., Strain J.J., Trinick T.R. Serum antioxidant potential, and lipoprotein oxidation in female smokers following vitamin C supplementation. Int J Food Sci Nutr 1996, 47:227-231.
48. Van Hoydonck P.G., Schouten E.G., Manuel Y.K.B., van Campenhout A., Hoppenbrouwers K.P., Temme E.H. Does vitamin C supplementation influence the levels of circulating oxidized ldl, sicam-1, svcam-1 and vwf-antigen in healthy male smokers?. Eur J Clin Nutr 2004, 58:1587-1593.
49. Vinson J.A., Jang J. In vitro and in vivo lipoprotein antioxidant effect of a citrus extract and ascorbic acid on normal and hypercholesterolemic human subjects. J Med Food 2001, 4:187-192.
50. Magen E., Viskoper R., Mishal J., Priluk R., Berezovsky A., Laszt A., et al. Resistant arterial hypertension and hyperlipidemia: atorvastatin, not vitamin C, for blood pressure control. Isr Med Assoc J 2004, 6:742-746.
51. Shidfar F., Keshavarz A., Jallali M., Miri R., Eshraghian M. Comparison of the effects of simultaneous administration of vitamin C and omega-3 fatty acids on lipoproteins, apo a-i, apo b, and malondialdehyde in hyperlipidemic patients. Int J Vitam Nutr Res 2003, 73:163-170.
52. Abdollahzad H., Eghtesadi S., Nourmohammadi I., Khadem-Ansari M., Nejad-Gashti H., Esmaillzadeh A. Effect of vitamin C supplementation on oxidative stress and lipid profiles in hemodialysis patients. Int J Vitam Nutr Res 2009, 79:281-287.
53. Khajehdehi P. Effect of vitamins on the lipid profile of patients on regular hemodialysis. Scand J Urol Nephrol 2000, 34:62-66.
54. Ramos R., Martinez-Castelao A. Lipoperoxidation and hemodialysis. Metabolism 2008, 57:1369-1374.
55. Osilesi O., Trout D.L., Ogunwole J.O., Glover E.E. Blood pressure and plasma lipids during ascorbic acid supplementation in borderline hypertensive and normotensive adults. Nutr Res (New York, N.Y.) 1991, 11:405-412.
56. Schindler T.H., Nitzsche E.U., Munzel T., Olschewski M., Brink I., Jeserich M., et al. Coronary vasoregulation in patients with various risk factors in response to cold pressor testing: contrasting myocardial blood flow responses to short- and long-term vitamin C administration. J Am Coll Cardiol 2003, 42:814-822.
57. Ingole S., Belorkar N.R., Waradkar P., Shrivastava M. Role of ascorbic acid supplementation on prevention of olanzapine induced metabolic side effects in schizophrenic patients. Indian J Public Health Res Dev 2011, 2:12-16.
58. Dietrich M., Block G., Hudes M., Morrow J.D., Norkus E.P., Traber M.G., et al. Antioxidant supplementation decreases lipid peroxidation biomarker f(2)-isoprostanes in plasma of smokers. Cancer Epidemiol Biomarkers Prev 2002, 11:7-13.
59. Khan F., Ray S., Craigie A.M., Kennedy G., Hill A., Barton K.L., et al. Lowering of oxidative stress improves endothelial function in healthy subjects with habitually low intake of fruit and vegetables: a randomized controlled trial of antioxidant- and polyphenol-rich blackcurrant juice. Free Radic Biol Med 2014, 72:232-237.
60. Mark S.D., Wang W., Fraumeni J.F., Li J.Y., Taylor P.R., Wang G.Q., et al. Lowered risks of hypertension and cerebrovascular disease after vitamin/mineral supplementation: the linxian nutrition intervention trial. Am J Epidemiol 1996, 143:658-664.
61. Harding A.H., Wareham N.J., Bingham S.A., Khaw K., Luben R., Welch A., et al. Plasma vitamin C level, fruit and vegetable consumption, and the risk of new-onset type 2 diabetes mellitus: the european prospective investigation of cancer-norfolk prospective study. Arch Intern Med 2008, 168:1493-1499.
62. Dakhale G.N., Chaudhari H.V., Shrivastava M. Supplementation of vitamin C reduces blood glucose and improves glycosylated hemoglobin in type 2 diabetes mellitus: a randomized, double-blind study. Adv Pharmacol Sci 2011, 2011:195271.
63. Ashor A.W., Siervo M., Lara J., Oggioni C., Mathers J.C. Antioxidant vitamin supplementation reduces arterial stiffness in adults: a systematic review and meta-analysis of randomized controlled trials. J Nutr 2014, 144:1594-1602.
64. van der Loo B., Bachschmid M., Spitzer V., Brey L., Ullrich V., Luscher T.F. Decreased plasma and tissue levels of vitamin C in a rat model of aging: implications for antioxidative defense. Biochem Biophys Res Commun 2003, 303:483-487.
65. Wilson J.X. Regulation of vitamin C transport. Annu Rev Nutr 2005, 25:105-125.
66. Baigent C., Keech A., Kearney P.M., Blackwell L., Buck G., Pollicino C., et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005, 366:1267-1278.